Knowing that profile before starting is the "test before you invest" approach an informed conversation with your provider, never a self-calculated dose
Further potentiation of SDF-1 could activate deleterious neurohormonal systems [74, 75], interact unfavorably with concurrently administered beta-adrenergic receptor blockers [71, 76], and promote progenitor cell infiltration, cardiac inflammation and adverse cardiac remodeling [77,78,79]
June 28, 2024: Study Reveals Potential Bone Density Reduction with GLP-1 Treatment In a recent study, Simon Jensen, Ph.D., and others found that GLP-1 treatment, without exercise, could lead to reduced bone density
Z., & St-Onge, M
Women with PCOS may notice more regular cycles, better energy, and even improved skin and reduced facial hair
Compounded tirzepatide allows custom doses between Zepbounds standard steps, which can help patients who hit GI side effects on standard titration